---
title: "Psych News Alert: FDA Approves First Drug for Binge-Eating Disorder"
description: Vyvanse—a medication approved in 2007 for attention-deficit/hyperactivity disorder (ADHD)—is the first medication to be approved by the U...
image: https://alert.psychnews.org/hubfs/Imported_Blog_Media/FDA-Logo-Jun-24-2025-09-28-21-0518-PM.png
---

 2/6/15 12:00 AM

# FDA Approves First Drug for Binge-Eating Disorder

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [ Psychiatric News Alert ](https://alert.psychnews.org/author/psychiatric-news-alert)

Share: [facebook-f icon ](http://www.facebook.com/share.php?u=https://alert.psychnews.org/2015/02/fda-approves-first-drug-for-binge.html) [linkedin-in icon ](http://www.linkedin.com/shareArticle?mini=true&url=https://alert.psychnews.org/2015/02/fda-approves-first-drug-for-binge.html) [Twitter icon ](https://twitter.com/intent/tweet?url=https://alert.psychnews.org/2015/02/fda-approves-first-drug-for-binge.html) [pinterest-p icon ](http://pinterest.com/pin/create/link/?url=https://alert.psychnews.org/2015/02/fda-approves-first-drug-for-binge.html) [envelope icon ](mailto:?body=https://alert.psychnews.org/2015/02/fda-approves-first-drug-for-binge.html)

| ![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/FDA-Logo-Jun-24-2025-09-28-23-0870-PM.png?width=200&height=80&name=FDA-Logo-Jun-24-2025-09-28-23-0870-PM.png) |  |
| --- | --- |

Vyvanse—a medication approved in 2007 for attention-deficit/hyperactivity disorder (ADHD)—is the first medication to be approved by the U.S. Food and Drug Administration (FDA) intended to treat binge-eating disorder. 

“Binge eating can cause serious health problems and difficulties with work, home, and social life,” said FDA Division of Psychiatry Products Director Mitchell Mathis, M.D. “The approval of Vyvanse provides physicians and patients with an effective option to help curb episodes of binge eating.” The drug was reviewed under the FDA’s priority review program, which expedites the review process of drugs that are intended to treated serious conditions for which there are limited therapy options available.

The FDA approved Vyvanse based on data generated from two clinical trials with 724 adults with moderate-to-severe binge-eating disorder. The results showed that participants taking Vyvanse experienced a decrease in the number of binge-eating days per week and had fewer obsessive-compulsive binge-eating behaviors compared with those taking placebo. Most serious side effects reported by individuals taking Vyvanse included dry mouth, insomnia, increased heart rate, and anxiety.

Vyvanse's Medication Guide notes the risks associated with the medication's use, such as increased risk of psychotic or manic symptoms, even in individuals without a prior history of psychotic illness. The FDA emphasized that Vyvanse is not approved for, or recommended for, weight loss.

Vyvanse is marketed by Shire U.S. Inc.

View the [FDA press announcement](http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm432543.htm) on Vyvanse. To read more about eating disorders and pharmacotherapies used to treat eating disorders, see the *Psychiatric News* article “[Expert Hopeful About Future of Treatment for Eating Disorders](http://psychnews.psychiatryonline.org/doi/full/10.1176/appi.pn.2014.3b8).”

[ADHD](https://alert.psychnews.org/tag/adhd), [FDA approval](https://alert.psychnews.org/tag/fda-approval), [binge eating disorder](https://alert.psychnews.org/tag/binge-eating-disorder), [Vyvanse](https://alert.psychnews.org/tag/vyvanse)

## Related posts

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/anorexia%20woman_57910114-Jun-24-2025-04-23-00-4976-PM.jpg?height=200&name=anorexia%20woman_57910114-Jun-24-2025-04-23-00-4976-PM.jpg) ](https://alert.psychnews.org/2012/04/antipsychotic-may-improve-anorexia.html)

[eating disorders](https://alert.psychnews.org/tag/eating-disorders), [olanzapine](https://alert.psychnews.org/tag/olanzapine), [anorexia nervosa](https://alert.psychnews.org/tag/anorexia-nervosa)

## [Antipsychotic May Improve Anorexia Nervosa](https://alert.psychnews.org/2012/04/antipsychotic-may-improve-anorexia.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 4/10/12 12:00 AM

[ Read more ](https://alert.psychnews.org/2012/04/antipsychotic-may-improve-anorexia.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/fda_2014_fw-Jun-24-2025-10-32-55-2803-PM.png?height=200&name=fda_2014_fw-Jun-24-2025-10-32-55-2803-PM.png) ](https://alert.psychnews.org/2016/05/fda-approves-first-medication-for.html)

[psychosis](https://alert.psychnews.org/tag/psychosis), [delusion](https://alert.psychnews.org/tag/delusion), [antipsychotics](https://alert.psychnews.org/tag/antipsychotics), [hallucination](https://alert.psychnews.org/tag/hallucination), [Parkinson's disease](https://alert.psychnews.org/tag/parkinsons-disease), [Food and Drug Administration](https://alert.psychnews.org/tag/food-and-drug-administration)

## [FDA Approves First Medication for Psychosis Associated With Parkinson’s Disease](https://alert.psychnews.org/2016/05/fda-approves-first-medication-for.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 5/2/16 12:00 AM

The Food and Drug Administration (FDA) on Friday approved Nuplazid (pimavanserin) tablets, the...

[ Read more ](https://alert.psychnews.org/2016/05/fda-approves-first-medication-for.html)

[![](https://alert.psychnews.org/hs-fs/hubfs/Imported_Blog_Media/Doctor_Patient_iStock_90120287_SMALL-Jun-24-2025-04-32-47-9341-PM.jpg?height=200&name=Doctor_Patient_iStock_90120287_SMALL-Jun-24-2025-04-32-47-9341-PM.jpg) ](https://alert.psychnews.org/2018/08/some-medications-for-alcohol-opioid-use.html)

[suicide](https://alert.psychnews.org/tag/suicide), [ajp in advance](https://alert.psychnews.org/tag/ajp-in-advance), [overdose](https://alert.psychnews.org/tag/overdose), [methadone](https://alert.psychnews.org/tag/methadone), [opioid use disorder](https://alert.psychnews.org/tag/opioid-use-disorder), [naltrexone](https://alert.psychnews.org/tag/naltrexone), [alcohol use disorder](https://alert.psychnews.org/tag/alcohol-use-disorder), [buprenorphine](https://alert.psychnews.org/tag/buprenorphine), [acamprosate](https://alert.psychnews.org/tag/acamprosate), [Yasmina Molero](https://alert.psychnews.org/tag/yasmina-molero), [arrests](https://alert.psychnews.org/tag/arrests)

## [Some Medications for Alcohol, Opioid Use Disorders May Reduce Suicidality, Criminal Behavior](https://alert.psychnews.org/2018/08/some-medications-for-alcohol-opioid-use.html)

![Picture of Psychiatric News Alert](https://alert.psychnews.org/hs-fs/hubfs/Psych%20News%20Email%20Banners/PN-Blue-Box_rgb.png?width=50&name=PN-Blue-Box_rgb.png) [Psychiatric News Alert](https://alert.psychnews.org/author/psychiatric-news-alert) 

 8/3/18 12:00 AM

Several medications approved to treat alcohol and opioid use disorders also appear to reduce...

[ Read more ](https://alert.psychnews.org/2018/08/some-medications-for-alcohol-opioid-use.html)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Psychiatric News Alert",
    "url" : "https://alert.psychnews.org/author/psychiatric-news-alert"
  },
  "dateModified" : "2025-06-24T21:30:15.538Z",
  "datePublished" : "2015-02-06T05:00:00.000Z",
  "headline" : "Psych News Alert: FDA Approves First Drug for Binge-Eating Disorder",
  "image" : [ "https://alert.psychnews.org/hubfs/Imported_Blog_Media/FDA-Logo-Jun-24-2025-09-28-21-0518-PM.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://alert.psychnews.org/2015/02/fda-approves-first-drug-for-binge.html",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://alert.psychnews.org/hubfs/PN-Blue-Box.jpg"
    }
  }
}
```